ANALYSIS OF ANTI-CANCER AND ANTI-AIDS CHEMICALS AND

药物资源处(PRB)，发展治疗 国家癌症治疗部(DCT)癌症治疗计划(DTP) 研究所(NCI)正在寻找一家承包商为以下项目提供分析服务 原料药和制剂药的分析 产品。这些分析的报告将作为评估的基础 这些材料是否适合用于筛查、药理学 研究、毒理学研究、配方研究或用于临床 审判。这些分析报告中提供的数据将提供给 食品和药物管理局(FDA)作为新调查的一部分 新的抗肿瘤和抗艾滋病药物(IND)申请。历史 数据汇总用于准备各种规格 散装药品。这些规格用于 采购行动以及这些产品的日常质量控制 材料。选定的承办商应具备以下经验： 原料药和临床用药的分析评价 产品，预计将拥有运营设备和 能力。

The Pharmaceutical Resources Branch (PRB), Developmental Therapeutics Program (DTP), Division of cancer Treatment (DCT), National Cancer Institute (NCI) is seeking a contractor to supply analytical services for the analysis of bulk pharmaceutical substances and formulated drug products. Reports of these analyses will be used as a basis for assessing the suitability of these materials for use for screening, pharmacological studies, toxicological studies, formulation studies, or for clinical trials. Data provided in these analytical reports will be supplied to the Food and Drug Administration (FDA) as part of the new Investigational New Drug (IND) filings for new antitumor and anti-AIDS agents. Historical summaries of the data are used in preparing specifications for the various bulk pharmaceutical substances. These specifications are used in procurement actions as well as for the routine quality control of these materials. The contractors selected should be experienced in the analytical assessment of bulk pharmaceutical substances and clinical drug products and will be expected to have operational equipment and capabilities.